http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108059673-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-065
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
filingDate 2017-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108059673-B
titleOfInvention Method for separating immunoglobulin IgG from human serum
abstract The invention relates to a method for separating immunoglobulin IgG from human serum, which comprises the following steps: 1) diluting human serum with buffer solution, adjusting pH to 6.0-8.0, and filtering with filter membrane to obtain human serum sample; 2) loading a human serum sample into a chromatographic column filled with a combined bionic chromatography medium, washing with an equilibrium buffer solution, eluting with an elution buffer solution, and collecting the eluate to obtain an immunoglobulin IgG solution; the combined bionic chromatography medium comprises a chromatography matrix and a combined ligand, wherein the chromatography matrix is a hydrophilic porous microsphere with hydroxyl; the sequence of the combined ligand is phenylalanine-tyrosine-glutamine-5-aminobenzimidazole; 3) and (3) carrying out ultrafiltration concentration on the immunoglobulin IgG solution to obtain the immunoglobulin IgG. The method can improve the efficiency and purity of immunoglobulin IgG separated from blood.
priorityDate 2017-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009127287-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13624
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23662384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423390850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450512062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86630341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447855610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454013444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21863217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892

Total number of triples: 35.